Guy, your 'moving forward opinion". imo is a sword that cuts bothways.
On one hand,obvious detriments like rabin, SEC settlement,an apparent Board member leaving who MAY have been a rabin supporter on the Board, and phase 1 coming to completion and data presentation for peer affirmation and acclaim, etc., etc., are all good, but my concern and objective is to make a profit after almost 10 long years on standing by caldwell's poorly executed actions to keep his company alive and rabin's actions apparently just making our financial picture worse and worse (under the eyes of the Board, i might add), with a prognosis in his or the company's business plan that foretells more of the same, ie. go it alone as long as they can, which clearly implies more dilution and more continuing erosion of our invested dollars, diminshing ability to do a RS, even if all should ever work out for the company.
We seem doomed for the penny crumbs that are left, unless our new interim ceo and Board have plans and proposals not shared with us to dramatically change our financial picture,etc. That would sure be nice.One aspect of that is clearly accelerated approval by the FDA to eventual commerciality, among many others.
As i noted in an earlier post, the increased recent trading volume for a few weeks now, after long period of share price stagnation, which still remains, may be a clue that something's up. Good or bad for investors, I don't know?
IMO, there are too many in 'the know' but' us.
In terms of all the seemingly buys (and sells) on any given day, you and I know those figures can be extremely manipulated and misleading, until a true breakout/pattern emerges up or down.
Sorry if it sounds crude, but I'm this after almost 10 years now, to make a profit. Sure I'm pleased for accolades to Lanza and Langer,but that doesn't seem to be translated in accolades for our share price. My assumption is, our finances, share price and exchange are so bad, we're not going anywhere, or even that worse case scenario that surprises lurk in upcoming data, which seems to to not be the case, hopefully, given positive statements by the company recently.
Our second try and the absolute necessity of a reverse split, imo, just does not feel doable again this year.
Some body cheer me up, please!
Market Data 
Markets 
AI
